FiercePharmaAsia—Factory expansion, warning for Korean drugmaker, new results in Takeda trial for relugolix and more
admin 6th October 2017 Uncategorised 0Welcome to this week’s FiercePharmaAsia report, which includes stories on Big Pharma’s expansion in the region, a U.S. regulatory warning for a South Korean drugmaker, new results in Takeda and Myovant’s trial for relugolix to treat uterine fibroids and more.
More: FiercePharmaAsia—Factory expansion, warning for Korean drugmaker, new results in Takeda trial for relugolix and more
Source: fierce